Related Experiment Videos
Chemotherapy for patients not benefitting from 5-fluorouracil therapy
G Luporini1, R Labianca, G Pancera
1Division of Medical Oncology, San Carlo Borromeo Hospital, Milan, Italy.
Journal of Surgical Oncology. Supplement
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
European journal of cancer (Oxford, England : 1990)·2019
Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2018
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation.
Journal of surgical oncology. Supplement·1993
Surgical risk in alcoholic cirrhotic postmenopausal women: prognostic value of levels of hormones.
Journal of surgical oncology. Supplement·1993
Preoperative evaluation of a patient for hepatic surgery.
Journal of surgical oncology. Supplement·1993
Molecular mechanisms of protease-mediated tumor invasiveness.
Journal of surgical oncology. Supplement·1993
Computed tomography of liver tumors.
Journal of surgical oncology. Supplement·1993
Effects of treatments in clinical trials: surgery.
Journal of surgical oncology. Supplement·1993
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026